Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,065 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term efficacy and safety of perampanel monotherapy in patients with newly diagnosed or currently untreated recurrent focal-onset seizures: Results from the open-label extension phase of FREEDOM (Study 342).
Yamamoto T, Lim SC, Ninomiya H, Kubota Y, Shin WC, Kim DW, Shin DJ, Iida K, Ochiai T, Matsunaga R, Hiramatsu H, Kim JH. Yamamoto T, et al. Among authors: kubota y. Epilepsy Res. 2024 Dec 20;210:107494. doi: 10.1016/j.eplepsyres.2024.107494. Online ahead of print. Epilepsy Res. 2024. PMID: 39788068
Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia.
Guarnera L, Gurnari C, Bravo-Perez C, Durmaz A, Williams ND, Awada H, Kawashima N, Ahmed A, Unlu S, Ogbue OD, Haddad C, Mandala A, Kubota Y, Bodo J, Crane GM, Rogers HJ, Maciejewski JP, Visconte V. Guarnera L, et al. Among authors: kubota y. Leukemia. 2025 Jan 5. doi: 10.1038/s41375-024-02429-x. Online ahead of print. Leukemia. 2025. PMID: 39755843 No abstract available.
Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors.
Ishiguro T, Takeda K, Takayanagi D, Mura E, Suzuki R, Tsurui T, Iriguchi N, Hirasawa Y, Ohkuma R, Shimokawa M, Ariizumi H, Kubota Y, Horiike A, Izumizaki M, Wada S, Yoshimura K, Hoffman RM, Tsunoda T. Ishiguro T, et al. Among authors: kubota y. Cancer Genomics Proteomics. 2025 Jan-Feb;22(1):1-12. doi: 10.21873/cgp.20481. Cancer Genomics Proteomics. 2025. PMID: 39730175 Free PMC article.
4,065 results